EXPRESS SCRIPTS, INC. for EXPRESS SCRIPTS, INC.

Postal POS

Postal Reform proposals and their impact on 6 day mail delivery (continuing resolution)

Contacted: Executive Office of the President (EOP); Labor, Dept of (DOL); Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); Government Accountability Office (GAO); Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); White House Office; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; Internal Revenue Service (IRS); Congressional Budget Office (CBO); Office of Personnel Management (OPM)

Defense DEF

Pharmacy issues related to Section 700 (Champus provisions) of the annual defense bill

Contacted: Health & Human Services, Dept of (HHS); Federal Trade Commission (FTC); Medicare Payment Advisory Commission (MedPAC); Health Resources & Services Administration (HRSA); Labor, Dept of (DOL); Congressional Budget Office (CBO); White House Office; SENATE; Food & Drug Administration (FDA); Internal Revenue Service (IRS); HOUSE OF REPRESENTATIVES; Office of Personnel Management (OPM); Executive Office of the President (EOP); Government Accountability Office (GAO); Centers For Medicare and Medicaid Services (CMS)

Medicare/Medicaid MMM

Health reform proposals that impact Medicare Part D such as formulary requirements, PBM disclosure provisions, closing of the Part D coverage gap. General reg/leg Part D issues such as direct negotiation (budget proposals). Statutory implementation of changes to the definition of AMP in Medicaid. Exclusion of specialty distributors' prompt pay discounts from the definition of Average Sales Price. Medicare audit and preferred network restrictions. S. 867, Medicare Prescription Drug Integrity andAnd Transparency Act of 2013. General issues regarding combatting Rx abuse in Medicare and Medicaid (pharmacy lock-in, etc)

Contacted: White House Office; SENATE; Labor, Dept of (DOL); Executive Office of the President (EOP); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); Internal Revenue Service (IRS); Government Accountability Office (GAO); Federal Trade Commission (FTC); Congressional Budget Office (CBO); Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); Office of Personnel Management (OPM); HOUSE OF REPRESENTATIVES

Bills named: S. 867 (113th)

Labor Issues/Antitrust/Workplace LBR

Legislation to exempt certain pharmacies from the antitrust laws for purposes of negotiating with payers (HR 1188)

Contacted: Internal Revenue Service (IRS); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Office of Personnel Management (OPM); Medicare Payment Advisory Commission (MedPAC); Federal Trade Commission (FTC); Congressional Budget Office (CBO); Executive Office of the President (EOP); Health Resources & Services Administration (HRSA); Labor, Dept of (DOL); Government Accountability Office (GAO); HOUSE OF REPRESENTATIVES; White House Office; SENATE

Bills named: H.R. 1188 (113th)

Pharmacy PHA

Policies related to the Federal Employees Health Benefit Program's pharmacy benefit (HR 1367); Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market (EHB, grandfathering, Rx quality, eRx, PBM disclosure requirements, MLR); regulatory implementation of a pathway for the approval of biosimilars; REMs; 340b program; policies placing restrictions on pharmacy benefit designissues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs). General issues dealing with prescription drug abuse including Medicare Lock-in programs. General issues dealing with regulating pharmacy drug compounding. S. 867, the Medicare Prescription Drug Program Integrity and Transparency Act.

Contacted: White House Office; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Internal Revenue Service (IRS); Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Federal Trade Commission (FTC); Labor, Dept of (DOL); Office of Personnel Management (OPM); Government Accountability Office (GAO); Congressional Budget Office (CBO); Health Resources & Services Administration (HRSA)

Bills named: H.R. 1367 (113th), S. 867 (113th)

Taxation/Internal Revenue Code TAX

Regulatory implementation of various tax provisions in the health reform legislation

Contacted: Labor, Dept of (DOL); Government Accountability Office (GAO); HOUSE OF REPRESENTATIVES; Internal Revenue Service (IRS); White House Office; Health Resources & Services Administration (HRSA); SENATE; Office of Personnel Management (OPM); Federal Trade Commission (FTC); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS); Congressional Budget Office (CBO); Food & Drug Administration (FDA)

Health Issues HCR

Regulatory policies related to health reform legislation: structure, drug benefits, disclosure Regulatory implementation of HITECH/Accounting of Disclosures Issues regarding making prescription drugs more affordable (generic user fees; pedigree; pathway for biosimilars; REMs).

Contacted: Health Resources & Services Administration (HRSA); SENATE; Congressional Budget Office (CBO); HOUSE OF REPRESENTATIVES; White House Office; Federal Trade Commission (FTC); Labor, Dept of (DOL); Executive Office of the President (EOP); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Government Accountability Office (GAO); Medicare Payment Advisory Commission (MedPAC); Internal Revenue Service (IRS); Centers For Medicare and Medicaid Services (CMS); Office of Personnel Management (OPM)